ICHNOS SCIENCES PRESENTS DATA SUPPORTING THREE ONCOLOGY ASSETS AT ASH 2022 ANNUAL MEETING

/PRNewswire/ -- Ichnos Sciences Inc., a global clinical-stage biotechnology company developing innovative multispecific immune cell engager antibodies in...

Related Keywords

New York ,United States ,American ,Tony Jiang ,Mario Perro ,Sanjay Mohan ,Cyril Konto ,Stefano Sammicheli ,American Society Of Hematology ,Head Of Communications ,Prnewswire Ichnos Sciences Inc ,Ichnos Sciences ,Ichnos Sciences Inc ,Corporate Affairs ,Oncology Research At Ichnos Sciences ,Sciences Inc ,American Society ,Annual Meeting ,Vice President ,Oncology Research ,Chief Executive Officer ,Dose Escalation ,Refractory Multiple Myeloma ,Antibody Innate Cell Modulator ,Dose Expansion Study ,